This study was designed to determine whether intracellular cyclic AMP augments myocardial contractility directly. Isolated guinea pig hearts were perfused with media containing cyclic AMP and other adenine nucleotides with or without 3% dimethylsulfoxide (DMSO) to facilitate myocardial uptake. Phosphorylase b to a transformation, determined fluorometrically, was used as an index of increased intracellular cyclic AMP. Heart rate, left ventricular pressure and dP/dt were assessed in isovolumic preparations. DMSO, 3%, did not significantly affect myocardial performance or mask increased contractility produced by epinephrine. Cyclic AMP, 10~*M, with or without DMSO depressed left ventricular pressure and dP/dt modestly, even when heart rate was maintained constant by pacing. Phosphorylase activation increased from a control value of 16.5 ± \M% (mean + SE, N = 1 2 ) to 40.0 ±3.1% (N = 19) following perfusion with ICHM cyclic AMP with 3* DMSO; DMSO alone increased phosphorylase much less. 5'-AMP with DMSO compared to DMSO alone did not activate phosphorylase. The results indicate that increased intracellular cyclic AMP, achieved in the absence of adrenergic stimulation, does not increase myocardial contractility. Thus, they support the view that the positive inotropic effect produced by catecholamines is not mediated by a direct action of cyclic AMP on the contractile apparatus.
• Cyclic AMP (adenosine 3',5'-monophosphate) is a second messenger mediating several metabolic actions of catecholamines on heart muscle. However, its role in mediating the positive inotropic effect produced by catecholamines has not yet been entirely clarified (1) (2) (3) (4) (5) . Some investigators have reported a direct positive inotropic effect of derivatives of cyclic AMP (6, 7), but others have observed no increase in myocardial contractility following administration of cyclic AMP itself under a variety of conditions (1, 8, 9) . This may be due to the nucleotide's poor penetration into cells (1) or to its susceptibility to hydrolysis by phosphodiesterase (10) . Since N G , 2'-O-dibutyryl cyclic AMP (dbcAMP) allegedly penetrates cells more readily and mimics certain metabolic effects of cyclic AMP (11) , it has been widely utilized in investigations concerned with biochemical mediation of the effects of catecholamines in several tissues. Recently, dbcAMP has been shown to evoke a protracted and slow rise in contractile force in cat capillary muscle (7) . However, because dbcAMP itself may be metabolically active prior to intracellular removal of the butyryl groups (12) , since it is not a naturally occurring metabolite and is 468 Circulation Rtiurcb, Vol. XXIX, Nortmbcr 1971 rapidly degraded in conventionally used buffers (13) , the interpretation of this finding is uncertain.
Although catecholamine-induced phosphorylase activation (phosphorylase b to a transformation) is mediated by cyclic AMP, it is clear that myocardial phosphorylase activation occurs after, and is not the mediator of, the contractile response produced by catecholamines on myocardium and smooth muscle (3, 4, 14, 15) . According to the prevailing view, the positive inotropic effect of catecholamines is mediated by cyclic AMP acting through an as yet undefined pathway, and the failure of exogenous cyclic AMP to produce a positive inotropic effect is due to poor penetration or hydrolysis or both. If this were the case, increased intracellular cyclic AMP should augment myocardial contractility. Therefore the present investigation was designed to determine whether increased intracellular cyclic AMP content, sufficient to activate phosphorylase but achieved in the absence of exogenous catecholamines, produces a positive inotropic effect. Myocardial cyclic AMP content was increased by perfusing guinea pig and rat hearts with cyclic AMP in aqueous solutions prepared with deionized water distilled twice in glass and in solutions containing dimethylsulfoxide (16, 17) to facilitate its transport into the cell, and myocardial phosphorylase b to a transformation was used as an index of increased intracellular cyclic AMP. Hearts were obtained from guinea pigs and rats weighing between 250 and 500 g. The animals were killed by a blow on the head, and effective retrograde aortic perfusion was established within 30 seconds with Krebs-Henseleit solution (KH) at 36°C at a constant pressure of 100 cm H 2 O. After an equilibration period of 20 minutes during which perfusion was continued with KH alone, experimental perfusions were initiated by opening a stopcock 2 cm proximal to the aortic root. The experimental perfusion fluid contained cyclic AMP and related compounds (10-°-10~SM) in KH alone; 1-7% DMSO (v/v) in KH (KH-DMSO); or cyclic AMP and related compounds ( 1 0 -B -1 0 -3 M ) in KH-DMSO. All solutions were equilibrated for at least 1 hour before use with 96$ O 2 -4% CO 2 and bubbled throughout the perfusion.
Two sets of experiments were performed. In the first, cardiac performance was assessed with the use of isovolumic beating hearts prepared by introducing a small rubber balloon attached to a stiff plastic cannula through the left atrium and securing it by a ligature around the cannula and the left arrial appendage. The fluid volume of the balloon was adjusted with a micrometer so that end-diastolic pressure was approximately 1 mm Hg. Recordings of left ventricular pressure (LVP) and dP/dt were obtained with a Statham P23Db transducer connected to an oscillograph. When the effect of epinephrine on cardiac performance was evaluated, 0.5-1 ml solutions of epinephrine, 1 0 -7 -1 0 -8 M , were continuously infused as previously described (18) .
In the second set of experiments, myocardial phosphorylase b, phosphorylase a, G-6-P, and glycogen were determined in empty beating hearts perfused under identical conditions. In general, empty bearing hearts were used to avoid interference with biochemical assays produced by components in the intraventricular balloons, although some biochemical studies were performed on isovolumic hearts as well. Heart rate was measured by electrocardiographic recordings obtained with the use of cotton wicks applied to the right atrium and right ventricle. The hearts beat spontaneously or the rate was controlled by a right ventricular epicardial electrode attached to a Grass stimulator.
TISSUE PREPARATION AND BIOCHEMICAL PROCEDURES
The perfused hearts were quickly frozen with Wollenberger tongs preeooled in liquid nitrogen (19) . Myocardium was pulverized at -20°C in a stainless steel mortar, preeooled to -I80°C. Samples weighing 15-20 mg were then homogenized at 0°C in 0.6 ml of a medium containing 60 mM potassium fluoride, 4 mM EDTA, pH 6.8, 20 mM y3-glycerophosphate, 15 mM mercaptoethanol, and 0.01% BSA. In some cases, to prevent phosphorylase b to a transformation more certainly during homogenizab'on, the procedure was performed at -20°C using 60% glycerol, 20 mM potassium fluoride, and 1 mM EDTA, pH 6.7. Results using both procedures were virtually identical. Following extraction for 10 minutes in homogenizing medium, the homogenate was centrifuged at 2400 g, and total phosphorylase activity and percent activation (-=-X 100) were determined in aliquots of the supernatant fraction. Assays were performed fluorometrically as described by Hardman et al. (20) . Aliquots were incubated for 8 minutes at 30°C in the presence or absence of 5'-AMP in a medium containing \% glycogen (purified according to Somogyi [21] ), 50 mM potassium phosphate, pH 6.7, and 0.1% BSA in a volume of 55 ^liters. The reaction was terminated with 5 ^liters of IN HC1 (redistilled prior to use). The reaction mixture was then neutralized and incubated for 10 minutes at 30°C with 250 ^liters of a solution containing 0.1M imidazole (recrystalized from ethyl acetate), Effect of DMSO on left ventricular pressure and heart rate in isovolumic beating hearts. Hearts were perfused with KH during a control period. Subsequently, the perfuslon medium was changed to one containing DMSO in concentrations indicated on the abscissa. Results represent the percent change (mean ± S.E.) compared to control values in six hearts in each group. 0.002M Mg (Ac)a, 5 /ig/ml PGM (100 IU/mg), 1 /Ag/ml G-6-PDH (140 IU/mg), 1 /tM GDP. In this medium, G-l-P formed is quantitatively converted to 6-phosphogluconate and NADP is reduced. Accordingly, after a 10-minute incubation, 2 ml of a solution containing 0.02M Na 2 CO r NaHCO a , pH 10, and 0.001M EDTA was added, and NADPH fluorescence was determined in a Turner fluorometer with Corning 5860 primary and 3387 and 4308 secondary filters. Myocardial G-6-P was assayed enzymatically according to Regen et al. (22) in neutralized perchloric acid myocardial extracts, and myocardial glycogen was determined in alkali hydrolysates by a modification of the procedure described by Neely et al. (23) .
STATISTICAL METHODS
Statistical comparisons were performed with Student's t-test for nonpaired samples. Data in the tables, figures, and text are presented as means ± SE.
Results

EFFECTS OF DMSO. CYCLIC AMP. 5 -AMP, AND ADENOSINE ON MYOCARDIAL CONTRACTILITY
Addition of DMSO to KH altered left ventricular function as shown in Figure 1 . In I mm Ho) dP/dt (mm Hq/scc) -2800
FIGURE 2
Effect of DMSO on isovolumic guinea pig heart. Records were made at paper speeds of 1 and 5 mm/ sec from hearts perfused with KH during a control period. The perfusion fluid was changed to one containing 3% DMSO during the interval indicated. A: heart with a spontaneous rate; B: heart rate maintained constant by pacing. 
Effect of epinephrine on isovolumic guinea pig heart. During the interval indicated, epinephrine was added at a final concentration of 1O-G M.
concentrations greater than 3%, DMSO depressed myocardial contractility and increased heart rate, findings in agreement with previous reports (24, 25) . Three percent DMSO altered LVP, dP/dt, and heart rate only transiently. Both LVP and dP/dt returned to control values within 60 seconds after initiation of DMSO infusion and remained stable during perfusion ( Fig. 2 ). On the basis of these results, the DMSO concentration chosen for subsequent experiments was 3%.
KH-DMSO did not depress the positive inotropic and chronotropic responses to 10~6M epinephrine ( Fig. 3) , nor did KH-DMSO with I O^M cyclic AMP (Table 1) . Similar results were obtained with isoproterenol in concentrations from 10~6 to 10~9M. Perfusion of guinea pig hearts with cyclic AMP in KH or in KH-DMSO in a final concentration of less than ICHM did not change LVP, dP/dt, or heart rate. When this concentration was exceeded, LVP remained constant or decreased modestly and heart rate was reduced. Results of these experiments are shown in Table 2 . Values in the table were obtained 30 seconds after onset of perfusion with cyclic AMP. A representative experiment is illustrated in Figure 4 . In six additional experiments perfusion with cyclic AMP in KH-DMSO was continued for 5 minutes, and heart rate was maintained constant at 300/min. LVP and dP/dt failed to increase during this period in every case.
As shown in Figure 5 , cyclic AMP slowed the perfused guinea pig heart by producing AV block and by decreasing atrial rate. Since maintaining a constant heart rate did not preclude the decreased LVP and the dP/dt Results expressed are average percent increase and range (in parpn!he=e-0 following epinephrine compared to base-line values obtained in each heart with the same perfusate without epinephrine. The cyclic AMP concentration was 10~4M. LVP and dP/dt were similar during control perfusions with all perfusates. Most isoproterenol studies were performed with heart rate maintained constant by electrical pacing to avoid rate-dependent changes in contractility produced by cyclic AMP in the perfusate, which slowed heart rate progressively. observed during cyclic AMP administration ( Fig. 6) , it is clear that myocardial depression in the guinea pig heart perfused with cyclic AMP was not entirely related to the bradycardia.
As shown in Table 2 , rat hearts behaved somewhat differently. Cyclic AMP slowed heart rate as in the guinea pig, but LVP and dP/dt increased. This reflects the well-known negative force treppe in the rat. Thus, when rat heart rate was maintained constant, there was no increase in LVP or dP/dt following cyclic AMP.
Since perfusion with cyclic AMP may increase intracellular 5'-AMP and adenosine concentration, additional experiments were performed to evaluate the effects of perfusion of guinea pig hearts with these agents themselves ( Table 2 ). In each of five experiments MHM 5'-AMP produced cardiac standstill within 30 seconds. Adenosine, 3 X ICHM, produced cardiac standstill (Fig.  7) , and ICHM adenosine reduced heart rate by an average of 36$. However, as shown in Figure 7 , when the heart was electrically paced at the control rate and adenosine perfusion continued, LVP and dP/dt increased compared to control values. Similar Effect of cyclic AMP on left ventricular pressure (LVP) and dP/dt in the isovolumic guinea pig heart. Heart rate was maintained constant by pacing. Cyclic AMP was added to the perfusate during the interval indicated.
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FIGURE 5
Changes in ventricular rate in the spontaneously beating isovolumic guinea pig heart produced by cyclic AMP. The electrocardiogram (top) was obtained with the use of bipolar leads from the right atrium and left ventricle. Left ventricular pressure was recorded simultaneously (bottom). Paper speeds were 25 mm/ sec and 1 mm/sec, respectively. Cyclic AMP was added to the perfusate during the interval indicated. Similar results were obtained with 10-4 M cyclic AMP.
results (not illustrated) were obtained with paced hearts perfused with 5'-AMP. Thus, since cyclic AMP slows the heart and decreases contractility and 5'-AMP and adenosine slow the heart but augment contractility, it is unlikely that the observed effects of cyclic AMP on cardiac function are due entirely to intracellular hydrolysis and accumulation of 5'-AMP or adenosine or both.
EFFECTS OF DMSO, CYCLIC AMP, AND 5-AMP ON MYOCARDIAL PHOSPHORYLASE ACTIVATION _P erfusion of empty beating guinea pig hearts with cyclic AMP in KH ( H H M )
FIGURE 6
Effect of cyclic AMP on isovolumic guinea pig heart. This recording is from an isovolumic guinea pig heart perfused with KH-DMSO as described in the text. Paper speed was I mm ( ) or 5 mm/sec (....).
Heart rate was S])ontaneous or maintained at the control rate by pacing where indicated. Cyclic AMP was added to the perfusate during the interval noted. Similar results were obtained with 10-4 M cyclic AMP.
increased the percent phosphorylase a (percent activation) from control values of 16.5 ±1.4* (N = 12) to 25.9 ±2.0* (N = 7 ) ( Fig. 8 ). Phosphorylase activation occurred as early as 5 seconds after initiation of cyclic AMP infusion and persisted as long as this agent was administered. Although KH-DMSO activated phosphorylase to some extent, marked additional activation occurred when cyclic AMP was added to this perfusate. Thus phosphorylase activation in hearts perfused with KH-DMSO was 23.7±1.8% ( N = 1 4 ) , whereas that in hearts perfused with KH-DMSO containing 1 ( H M cyclic AMP increased to 47.1 ±2.1% (N = 7 ) within the first 5 seconds following onset of cyclic AMP infusion and remained markedly elevated (40.2±3.1% ( N = 1 9 ) throughout 150 seconds of infusion (Fig. 8) . In additional experiments with isovolumic hearts, 10~^M cyclic AMP in KH-DMSO increased percent phosphorylase activation from 21.2 ± 3.7% (N = 4 ) to 44.6 ±3.1% (N = 4 ) ; K H M 5'-AMP in KH-DMSO did not activate phosphorylase (Table  3) . Although total myocardial phosphorylase activity was modestly reduced in hearts perfused with KH-DMSO, as a result of increased tissue water content, none of the nucleotides affected total phosphorylase in dP/dt (mm Hg/sec) -2800L
|-Adenosine (3»IO" FIGURE 7
Effect of adenosine on left ventricular pressure and dP/dt in the isovolumic guinea pig heart. Paper speed was 5 mm/sec (••••) or 1 mm/sec ( ) . Heart rate was either spontaneous or maintained at the control rate by pacing where indicated. Adenosine was added to the perfusate during the interval indicated. Similar results were obtained with 10-4 M adenosine. 
DURATION OF c-AMP INFUSION (minutes) FIGURE 8
Transformation of phosphorylase b to a in the isolated perfused guinea pig heart exposed to cyclic AMP (cAMP heart tissue. There was no apparent increase in phosphorylase activation in three experiments in which cyclic AMP or 5'-AMP ( 1(HM final concentration) was added to tissue from hearts perfused with KH-DMSO at the time of freezing and pulverization. In addition, in each of two experiments in which cyclic AMP ( 1(HM final concentration) was added to tissue homogenates, there was no apparent phosphorylase activation. DMSO added to homogenates of tissues perfused with KH did not influence the observed percent phosphorylase a in any of three experiments.
MYOCARDIAL GLUCOSE-6-PHOSPHATE AND GLYCOGEN CONTENT FOLLOWING PERFUSION OF GUINEA PIG HEARTS WITH CYCLIC AMP
To assess the metabolic effect of increased myocardial phosphorylase activation observed during perfusion of guinea pig hearts with cyclic AMP, myocardial glycogen and G-6-P content were determined in perfused hearts paced at a rate of 300. Control samples were obtained after 30-minute perfusion with KH. Perfusion was then continued for 5 minutes with either KH or KH-DMSO alone or containing IO^M cyclic AMP or 5'-AMP. G-6-P and glycogen concentrations remained constant during the 5-minute experimental period when perfusion was maintained with KH alone. Control G-6-P concentration was 0.69 ±0.07 nmoles/mg protein (N = 12) and did not change significantly following DMSO alone (0.72 ±0.04, N = 5 ) . Control glycogen concentration was 16.2 ± 1.0 ^ig/mg protein ( N = 20) and did not change significantly following DMSO alone (17.6 ±1.3, N = 1 0 ) even though phosphorylase a increased. This may reflect increased glycogen synthesis related to increased glucose uptake with DMSO. However, cyclic AMP ( I O^M ) in KH-DMSO decreased myocardial glycogen concentration to 9.1 ±0.9 (N = 10), P<0.01 compared to concentrations in control samples and in those obtained following perfusion with KH-DMSO. In addition, cyclic AMP in KH-DMSO decreased G-6-P to 0.48 ± 0.07 (N = 7, P<0.02). These changes in myocardial constituents following perfusion with cychc AMP in DMSO support the conclusion that the nucleotide penetrated the intracellular space and subsequently affected myocardial metabolism. The control values for myocardial glycogen are slightly lower than those reported in some studies. However, the relatively high perfusion pressure utilized in the present study is sufficient to account for some glycogen depletion, as pointed out by Neely et al. (23) .
Myocardial Phosphorylase and Apparent Percent Phosphorylase a Following Nudeotide Administration
Discussion
The major finding of this study is that when cyclic AMP mediates myocardial phosphorylase b to a transformation in isolated perfused guinea pig hearts it does not augment ventricular performance. These results are consistent with recent evidence that when intracellular accumulation of cyclic AMP in perfusates is facilitated by low temperature there is no associated increase in myocardial contractility (26).
Although doses of epinephrine sufficient to activate phosphorylase increase contractility consistently in the dog heart, small doses may elicit a positive inotropic response in the absence of phosphorylase transformation (27) . In view of the extent of phosphorylase transformation during cyclic AMP infusion, our results suggest that augmented intracellular cychc AMP does not exert a positive inotropic effect.
In the present study, the hearts were frozen immediately with Wollenberger tongs to minimize possible artifactual phosphorylase activation (19) . Observed activation was virtually identical whether tissue was prepared at 0°C or -20°C. The proportion of phosphorylase a in hearts perfused with KH alone is in accord with previous studies of guinea pig heart (15, 28) . The addition of cyclic AMP or 5'-AMP (final concentration Circulation Research, Vol. XXIX, Novtmber 1971 10~~*M) to the frozen, pulverized tissue prior to extraction did not increase apparent activation. Changes in myocardial glycogen following perfusion with cyclic AMP are consistent with phosphorylase activation during perfusion rather than during preparation and extraction of the tissue. The somewhat unanticipated decrease in G-6-P seen in hearts perfused with cyclic AMP may indicate cyclic AMP relief of citrate and ATP inhibition of phosphofructokinase (29) favoring decreased G-6-P concentration.
Phosphorylase activity may be influenced by factors other than the direct action of cyclic AMP. Since 5'-AMP is an allosteric activator of phosphorylase b, accumulation of 5'-AMP inside the cell from breakdown of cyclic AMP could have produced cofactordependent activation of phosphorylase b in perfused hearts. Although this mechanism might account for the glycogenolysis seen, it would not account for the phosphorylase b to a transformation observed in vitro. Addition of IO^M 5'-AMP to the perfusate or to the pulverized tissue did not lead to glycogenolysis. Furthermore, even if all cyclic AMP in perfusates were converted to 5'-AMP, its concentration following dilution of the tissue sample would be too low to spuriously influence determination of phosphorylase b activity (30) .
Our results contrast with findings of Levine et al. in studies utilizing intact dogs and man (31, 32) , in which large doses of cyclic AMP given intravenously resulted in increased heart rate and cardiac output. However, cychc AMP effects on other organs leading to changes in circulating metabolites or breakdown to adenosine with consequent myocardial catecholamine release were not excluded (33) . On the other hand, exogenous cyclic AMP does not augment cardiac performance in more easily controlled preparations (1, (34) (35) (36) . Recently, the positive inotropic and chronorropic responses to norepmephrine have been dissociated from changes in myocardial cyclic AMP with isopropylmethoxamine (5).
The diminution of atrial automaticity and atrioventricular conduction associated with cyclic AMP in the present study may be related to a direct action of adenine nucleotides on the cell membrane (37) . Although dbcAMP exhibited a positive chronotropic effect on beating cultured cells from rat hearts, cyclic AMP itself, even in massive concentrations, did not (38) . Negative chronotropic effects similar to those seen with cyclic AMP occurred during 5'-AMP and adenosine infusion (33) . However, when heart rate was kept constant by pacing, adenosine increased LVP and dP/dt, perhaps because of endogenous release of catecholamines (33) . On the other hand, although cyclic AMP decreased heart rate in spontaneously beating hearts as did adenosine and 5'-AMP, it decreased rather than increased LVP and dP/dt when heart rate was maintained constant by pacing. Thus, cyclic AMP effects are not due exclusively to accumulation of intracellular adenosine or 5'-AMP nor to rate-related depression of contractility.
The results of this investigation differ from a recent report by Kukovetz and Poch (39) in which perfusion pressures were considerably lower, and accordingly contractility may have been depressed. The long latent period (4-6 minutes) and protracted (15-30 minutes) change in ventricular pressure they observed following a single bolus injection of dbcAMP into the perfusate may have been due to partial breakdown of the nucleotide to adenosine, coronary vasodilatation, and altered coronary flow, oxygen, and substrate availability. Since the preparations were not isovolumic, altered ventricular pressures may have reflected changes in ventricular volume following dbcAMP administration rather than a change in inotropic state. The large doses of nucleotides may have led to myocardial catecholamine release (33) , reflected by increased heart rate. Finally, the apparent increase in left ventricular pressure occurred in less than two-thirds of the hearts studied.
Interpretation of results from studies employing dbcAMP requires caution. Metabolic and physiological effects produced by cyclic AMP and dbcAMP may differ (40) , dbcAMP may undergo rapid degradation in conven-tional buffers (13) , and effects seen only with very large concentrations may be due to breakdown products. Thus, the reported increase in beating rate of cultured cells from young rat hearts (38) and the gradual, positive effect in isolated cat papillary muscle (7) exposed to dbcAMP, do not necessarily apply to the physiological role of cyclic AMP itself.
One might argue that in the present study extracellular cyclic AMP, or DMSO in the perfusate, or both, masked positive inotropic effects mediated by a critical intracellular pool of cyclic AMP augmented by catecholamines. However, the data in Table 1 militate against this possibility. Thus, catecholamine-induced increments in contractility were not inhibited by cyclic AMP in KH-DMSO. Even when small doses of isoproterenol were administered in the presence of DMSO and the nucleotide, the increased contractility observed was similar to that seen in the absence of cyclic AMP, DMSO, or both.
The present results do not exclude the possibility that the positive inotropic effect produced by catecholamines may depend on augmentation of a localized, partitioned intracellular pool of cyclic AMP unaffected in this investigation. On the other hand, they are consistent with the hypothesis of Rasmussen and Tenenhouse (41) that catecholamine activation of adenyl cyclase results in conversion of membrane-bound ATP to cyclic AMP and that consequently calcium is released from the Ca 2 *-membrane-ATP complex. Catecholamine effects on contractility may depend on increased calcium released by this mechanism rather than on a direct effect of cyclic AMP itself. The evidence obtained in the present investigation indicates that cyclic AMP entered the intracellular space without increasing contractility. Thus it supports the conclusion that the positive inotropic effect produced by catecholamines is not mediated by cyclic AMP.
